ESTRO Guide 2018

• Have a general understanding of principles in geriatric oncology and integrate geriatric oncology assessment into clinical practice involving NMSC patients • Summarise the latest technical developments and gain knowledge of future directions in research and clinical trials in the management of NMSC. COURSE CONTENT • Epidemiology,prevention, pathology and bio- markers of NMSC • The role of imaging in diagnosis and treatment of NMSC • Surgical and non-surgical treatments of NMSC • Physics andmould room input in dermatological radiotherapy and brachytherapy • Radiobiology of the skin • Follow-up andmanagement of side effects during and after skin cancer treatment • Role of allied health care professionals inNMSC management • Concept and management of high risk, locally advanced and metastatic NMSC • NMSC in special circumstances and rare skin pathologies • Clinical consultation of NMSC patient • Role of multidisciplinary teammeetings in the management of NMSC • Overview of current research, clinical trials and technical developments in the management of NMSC. PREREQUISITES Before commencing this course participants should: • Revise anatomy of the skin and lymphatic system with common drainage routes • Have at least basic knowledge of main NMSC types and their clinical presentation • Have at least basic knowledge of standard surgical and non-surgical treatment modalities inNMSC

• Have at least basic experience with radiation therapy for NMSC patients. If the participant is not a radiation oncologist or clinical oncologist (including training post) they should be involved in multidisciplinary case discussions or have special interest in the management of NMSC patients • Be prepared to ask questions and contribute to live and interactive discussions. TEACHINGMETHODS Three day course including: • Didactic lectures • Special workshops, debates and case discussions • Interactive sessions. KEYWORDS Non-melanoma skin cancer, multimodality management, surgery, radiotherapy, high risk non-melanoma skin cancer, volume delineation, side effects, cosmesis, quality of life, geriatric assessment. ACCREDITATION Application for CME recognitionwill be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the AmericanMedical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office. METHODS OF ASSESSMENT • Multiple choice questions • Mark-out exercises • Evaluation form.

ROADMAP

MULTIMODAL CANCER TREATMENT

RADIATION ONCOLOGIST, OTHER SPECIALIST

FACULTY COURSE DIRECTOR

Agata Rembielak, Radiation Oncologist and Clinical Oncologist, The Christie Hospital, Manchester (UK)

TEACHERS • Alessandro Di Stefani, Dermatologist and Dermatopathologist, Università Cattolica del Sacro Cuore, Rome (IT) • Sharon Gardner, Tissue Viability Nurse, The Christie Hospital, Manchester (UK) • György Kovács, Radiation Oncologist, University of Lübeck, Lübeck (DE) • Marc Moncrieff, Plastic and Reconstructive Surgeon, Mohs’ Surgeon, Norfolk & Norwich University Hospital, Norwich (UK) • Anita O’Donovan, Radiographer with research interest in geriatric oncology, Trinity College, Dublin (IE) • Christian Rose, Dermatopathologist, Universitätsklinikum Schleswig-Holstein, Lübeck (DE) • Anysja Zuchora, Medical Physicist, Galway University Hospital, Galway (IE)

SCHOOL

Agata Rembielak

81